1. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine 2. Department of Experimental Research 3. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China 4. Department of Hepatobiliary Oncology, Affiliated Tumor Hospital, Guangzhou Medical University, Guangzhou 510095, China 5. Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
The existence of cancer stem cells, stem-like cancer cells (SLCCs), or tumor-initiating cells is considered as the cause of tumor formation and recurrence, indicating the importance of studying novel therapy that targets SLCCs. The origin of SLCCs is controversial because of two competing hypotheses: SLCCs are either transformed from tissue adult stem cells or dedifferentiated from transformed progenitor cells. Our previous research demonstrates that SLCCs are inducible by increasing genomic instability in cancer cells. In this study, to block the emergence of SLCCs, aminoethyl isothiourea (AET), a compound that clears free radicals and is used to protect patients from radioactive exposure, was used as an agent that maintains genomic stability in combination with mitomycin C (MMC), a commonly used chemotherapeutic drug that damages DNA. Using a rabbit tumor model with VX2 hepatic carcinoma, we found that MMC alone increased lung metastases and disadvantaged survival outcome, but the combination of MMC and AET reversed this effect and even prolonged overall survival. Moreover, in a VX2 xenograft model by immunocompromised mice, MMC alone enriched tumor-initiating cells, but the administration of MMC in combination with AET eliminated tumor cells effectively. Furthermore, MMC alone enhanced genomic instability, but MMC combined with AET attenuated the extent of genomic instability in primary VX2 tumor tissue. Taken together, our data suggest that the genomic protector AET can inhibit the induction of SLCCs, and this combination treatment by AET and cytotoxic agents should be considered as a promising strategy for future clinical evaluation.
. [J]. Frontiers of Medicine, 2015, 9(1): 57-62.
Yi Liang,Qisheng Feng,Jian Hong,Futuo Feng,Yi Sang,Wenrong Hu,Miao Xu,Roujun Peng,Tiebang Kang,Jinxin Bei,Yixin Zeng. Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells. Front. Med., 2015, 9(1): 57-62.
Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, Zeng YX. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 2010; 285(7): 4931-4940
https://doi.org/10.1074/jbc.M109.048397
pmid: 20007324
Carr CJ, Huff JE, Fisher KD, Huber TE. Protective agents modifying biological effects of radiation. A selective review. Arch Environ Health 1970; 21(1): 88-98
https://doi.org/10.1080/00039896.1970.10667199
pmid: 4914546
10
Akoun G. Pharmacologic and clinical study of 2-amino-ethyl-isothiouronium hydrobromide: utilization in neurologic therapy. Psychiatr Neurol Neurochir 1964; 67: 278-288 (in French)
pmid: 14168887
11
Kidd JG, Rous P. A Transplantable Rabbit Carcinoma Originating in a Virus-Induced Papilloma and Containing the Virus in Masked or Altered Form. J Exp Med 1940; 71(6): 813-838
https://doi.org/10.1084/jem.71.6.813
pmid: 19871000
12
Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 1990; 49(1): 92-97
https://doi.org/10.1016/0022-4804(90)90116-J
pmid: 2359299
13
Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS ONE 2013; 8(8): e74327
https://doi.org/10.1371/journal.pone.0074327
pmid: 23977399
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131(6): 1109-1123
https://doi.org/10.1016/j.cell.2007.10.054
pmid: 18083101
16
Laborit H, Broussolle B, Jouany JM, Niaussat P, Reynier M, Weber B. Pharmacological study of 2-aminoethylisothiuronium hydrobromide (AET). Therapie 1959; 14: 1116-1135 (in French)
pmid: 14413213
Doherty DG, Burnett WT Jr. Protective effect of S, beta-aminoethylisothiuronium-Br-HBr and related compounds against x-radiation death in mice. Proc Soc Exp Biol Med 1955; 89(2): 312-314
https://doi.org/10.3181/00379727-89-21795
pmid: 14395303
Pritsos CA, Sartorelli AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986; 46(7): 3528-3532
pmid: 3011250